Home » Tenders » Americas » Brazil » Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula... Tender

Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula Dura... Tender

Download Documents

FEDERAL DISTRICT GOVERNMENT - GDF has floated a tender for Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula Dura 75 Mg and Others, According to Specifications and Quantities Contained in Annex i of the Notice.. The project location is Brazil and the tender is closing on 19 Mar 2024. The tender notice number is 90027/2024, while the TOT Ref Number is 98412726. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula Dura 75 Mg and Others, According to Specifications and Quantities Contained in Annex i of the Notice.

Deadline : 19 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98412726

Document Ref. No. : 90027/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Object: Electronic Auction - Process for potential purchase/contracting of DABRAFENIBE (MESYLATE) CAPSULA DURA 75 MG and others, according to specifications and quantities contained in Annex I of the Notice.

UASG Code: 926119

Notice as of: 07/03/ 2024 from 08:00 to 12:00 and from 13:00 to 17:0019981d172c851bd4e8a1788d5726c2d3

Proposal Delivery: from 03/07/2024 at 08:00

DABRAFENIB, CONCENTRATION 75 MG

Quantity: 3240

DABRAFENIB, CONCENTRATION 75 MG

Quantity: 1080

FLUNITRAZEPAM, DOSAGE 1 MG

Quantity: 3240

MEDICAL EXTRACT, ACTIVE INGREDIENT GLYCINE MAX (L.) MERRIL, CONCENTRATION 150 MG

Quantity: 216019981d172c851bd4e8a1788d5726c2d3

HYDROXIZINE HYDROCHLORIDE, DOSAGE 25 MG

Quantity: 2160

INSULIN, ASPART ORIGIN, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATOR

Quantity: 108

LENVATINIB, CONCENTRATION 4 MG

Quantity: 1620

LENVATINIB, CONCENTRATION 4 MG

Quantity: 540

LEV19981d172c851bd4e8a1788d5726c2d3ODOPA, COMPOSITION ASSOCIATED WITH BENSERAZIDE, DOSAGE 100MG 25MG, PRESENTATION DISPERSIBLE TABLETS

Quantity: 10800

NUSINERSENE, CONCENTRATION 2.4 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 27

NUSINERSENE, CONCENTRATION 2.4 MG/ML, FOR MA PHARMACEUTICAL INJECTABLE SOLUTION

Quantity: 919981d172c851bd4e8a1788d5726c2d3

ORLISTATE, DOSAGE 120 MG

Quantity: 2160